Eberherr C - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.

Eberherr C, Beck A, Vokuhl C, Becker K, Häberle B, Von Schweinitz D, Kappler R. Eberherr C, et al. Int J Oncol. 2019 May;54(5):1853-1863. doi: 10.3892/ijo.2019.4741. Epub 2019 Mar 5. Int J Oncol. 2019. PMID: 30864675

Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.

Beck A, Eberherr C, Hagemann M, Cairo S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R. Beck A, et al. Among authors: eberherr c. Cancer Biol Ther. 2016 Nov;17(11):1168-1176. doi: 10.1080/15384047.2016.1235664. Epub 2016 Sep 16. Cancer Biol Ther. 2016. PMID: 27635950 Free PMC article.

High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.

Weiss JBW, Wagner AE, Eberherr C, Häberle B, Vokuhl C, von Schweinitz D, Kappler R. Weiss JBW, et al. Among authors: eberherr c. Cancer Biomark. 2020;28(3):321-328. doi: 10.3233/CBM-191390. Cancer Biomark. 2020. PMID: 32390604

Vessel adherent growth represents a major challenge in the surgical resection of neuroblastoma and Is associated with adverse outcome.

Mühling J, Eberherr C, Müller Höcker J, Grote V, von Schweinitz D, Kappler R, Fröba-Pohl A. Mühling J, et al. Among authors: eberherr c. J Pediatr Surg. 2019 Nov;54(11):2336-2342. doi: 10.1016/j.jpedsurg.2019.07.012. Epub 2019 Jul 23. J Pediatr Surg. 2019. PMID: 31402147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters